VJHemOnc is committed to improving our service to you

ICML 2019 | Tisagenlecleucel in R/R follicular lymphoma: ELARA data

VJHemOnc is committed to improving our service to you

Michael Dickinson

Michael Dickinson, MBBS, DMedSc, FRACP, FRACPA, Peter MacCallum Cancer Centre, Melbourne, Australia, discusses the ELARA trial (NCT03568461). This Phase II trial assessed the efficacy and safety of tisagenlecleucel in adult patients with relapsed/refractory follicular lymphoma. This interview took place at the 15th International Conference on Malignant Lymphoma (ICML), in Lugano, Switzerland.

Share this video  
Similar topics

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter